Mizolastine CAS: 108612-45-9

CAS NO: 108612-45-9
Mizolastine
Chemical Name: Mizolastine
Molecular Formula: C24H25FN6O
Formula Weight: 432.49
CAS No.: 108612-45-9
Description Review
Description

Mizolastine is an antihistamine medication used to treat allergic rhinitis and chronic urticaria. It works by blocking the effects of histamine, a substance in the body that causes allergic symptoms such as sneezing, itching, and runny nose.

Chemical Name:

The chemical name of Mizolastine is 1-[(4-methoxyphenyl)methyl]-N-[2-(pyrimidin-2-yl)ethyl]piperidine-4-carboxamide.

Molecular Formula:

The molecular formula of Mizolastine is C21H26N4O2.

Formula Weight:

The formula weight of Mizolastine is 370.46 g/mol.

CAS No:

The CAS number of Mizolastine is 108612-45-9.

Top Ten Keywords from Google and Synonyms:

  1. Antihistamine medication
  2. Allergic rhinitis treatment
  3. Chronic urticaria therapy
  4. Mizolastine
  5. H1 receptor antagonist
  6. Histamine blocker
  7. Anti-allergy drug
  8. Seasonal allergy relief
  9. Hay fever management
  10. Allergic conjunctivitis medication

Synonyms: Mizollen, Telfastin, Micolysin, Alertal, Mizol, Minalka, Allexo, Mizolastina

Health Benefits of Mizolastine:

Mizolastine is primarily used to treat allergic rhinitis and chronic urticaria. It helps in reducing symptoms such as sneezing, itching, runny nose, and skin rash. Additionally, it can improve overall quality of life for allergy sufferers.

Potential Effects:

Mizolastine is an H1-receptor antagonist that works by blocking the effects of histamine in the body. Histamine is released during an allergic reaction and causes symptoms such as itching, sneezing, and runny nose. By blocking the effects of histamine, Mizolastine reduces these symptoms and provides relief from allergy-related discomfort.

Product Mechanism:

Mizolastine works by binding to and blocking the H1 receptors in the body that are responsible for the effects of histamine. By doing so, it prevents the release of other inflammatory mediators such as leukotrienes and prostaglandins, which can further exacerbate allergy symptoms. This mechanism of action makes Mizolastine effective in treating both nasal and skin symptoms associated with allergies.

Safety:

Mizolastine is generally considered safe when used as directed. However, like all medications, it may cause side effects in some people. It is not recommended for certain patients, such as those who have a history of heart disease or liver impairment. It should also be used with caution in people with kidney disease, pregnancy, or lactation.

Side Effects:

Common side effects of Mizolastine include drowsiness, dry mouth, and headache. Rare but serious side effects may include arrhythmia, angioedema, and anaphylaxis. Patients who experience any of these symptoms should seek immediate medical attention.

Dosing Information:

The recommended dose of Mizolastine depends on the condition being treated and the individual patient's response to the medication. For allergic rhinitis, the usual dose is 10 mg taken orally once daily. For chronic urticaria, the recommended dose is 10-20 mg per day taken orally. Mizolastine should be taken with food to increase absorption.

Conclusion:

Mizolastine is an antihistamine medication used to treat allergic rhinitis and chronic urticaria. It works by blocking the effects of histamine in the body, providing relief from allergy symptoms such as itching, sneezing, and skin rash. While it is generally safe and effective, it may cause side effects in some patients and is not recommended for certain populations. If you have any questions about Mizolastine or its use, please consult your healthcare provider

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code